CMS Proposes Creating Permanent Framework for Medicare Drug Price Negotiations

The Supreme Court declined to consider appeals by pharma companies seeking to challenge the government’s ability to negotiate prescription drug prices.

Medicare and Medicaid Administrator Mehmet Oz speaks during a press briefing in the James S. Brady Press Briefing Room in the White House, in Washington on June 2, 2026. Mandel Ngan/AFP via Getty Images

The U.S. Centers for Medicare and Medicaid Services (CMS) has proposed a permanent framework for its Medicare drug price negotiation program that it said will make the process for lowering costs more transparent.

The agency said in a June 12 statement that the proposed rule also aimed at providing long-term certainty for drugmakers participating in the program.